Intuitive Surgical (ISRG) has an average rating of overweight and mean price target of $479.86, according to analysts polled by FactSet.
What else is happening in Research?
Research
BCE Upgraded to Buy, Price Target Lifted by BofA Securities
BCE (BCE.TO) was upgraded to buy from underperform by BofA Securities on Tuesday on the outlook for revenue from a data center under construction in Saskatchewan and its Ziply Fiber internet unit.The price target was raised to C$38 from C$34. "Our conviction rests on improving permitting, strong US, fiber gross additions and growing visibility into growing contracted data-center revenue," BofA Securities said in a note.In March, BCE said the Saskatchewan project will be the "largest purpose-built AI data centre development anywhere in Canada."Price: $32.36, Change: $+0.97, Percent Change: +3.11%
$BCE.TO
Research
Chardan Downgrades Tenax Therapeutics to Neutral From Buy, Adjusts Price Target to $5 From $27
Tenax Therapeutics (TENX) has an average rating of buy and mean price target of $14.78, according to analysts polled by FactSet.Price: $1.70, Change: $+0.32, Percent Change: +23.27%
$TENX
Research
Calfrac Well Services Upgraded to Outperform at ATB
Calfrac Well Services (CFW.TO) was upgraded to outperform from sector perform at ATB Cormark Capital Markets on Tuesday.Analyst Tim Monachello maintained a price target of C$9 on shares of the Calgary-based oilfield services company"We believe CFW is well positioned to take advantage of an improving North American outlook amid strengthening demand and structural efficiency gains following recent fleet redeployments," Monachello said in a note to clients.Price: $7.30, Change: $+0.41, Percent Change: +5.95%
$CFW.TO